1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : OTHER CONSUMER SERVICES
  4. MEDIROM HEALTHCARE TECHNOLOGIES INC - ADR
MEDIROM Healthcare Technologies Inc - ADR
XNAS: MRM
0.54-0.03(-5.26%)
35,237
XNAS Volume

XNAS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

MEDIROM Healthcare Tech Inc (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

MEDIROM Healthcare Tech Inc (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue MEDIROM Healthcare Tech Inc (ADR) Jun-2025 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEUTRAL

    Quarterly Net Profit MEDIROM Healthcare Tech Inc (ADR) Jun-2025 Quarterly Net Profit is $0 Million which is growth of 0% YoY.

MEDIROM Healthcare Technologies Inc - ADR, Earnings Report - Quarterly Results, standalone, All financials are in JPY Million and price data in USD
IndicatorGraphJun '25Dec '24Jun '24Dec '23Jun '23Dec '22Jun '22Dec '21Jun '21Dec '20Jun '20Dec '19
Operating Rev.
------------
Cost Of Rev.
------------
Gross Profit
------------
⌄
----
Operating Profit
----
------------
Profit Before Tax
------------
Tax
------------
⌄
------------
Diluted NI Avail to Com Stockholders Ann.
------------
Basic EPS
------------
Diluted EPS After ExtraOrdinary
------------
Number Of Shares End
----4.94.94.94.94.94.84.74.7
Net Income Continuing Discontinued Operations
------------
Normalized Income
------------
Interest Income
------------
Interest
------------
Net Interest Income
------------
EBIT
------------
EBITDA
------------
Reconciled Cost Of Rev.
------------
Reconciled Depr.
------------
Profit From Continuing Operations
------------
Normalized EBITDA
------------
*All financials are in JPY Million and price data in USD

MEDIROM Healthcare Tech Inc (ADR) competitor comparison and performance snapshot within industry

MEDIROM Healthcare Tech Inc (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2024 – 11 year history

  • POSITIVE

    Annual Revenue MEDIROM Healthcare Tech Inc (ADR) Dec-2024 Annual Revenue is $8,299 Million which is growth of 21.5% YoY.

  • POSITIVE

    Annual Net Profit MEDIROM Healthcare Tech Inc (ADR) Dec-2024 Annual Net Profit is $149 Million which is growth of 29.3% YoY.

MEDIROM Healthcare Technologies Inc - ADR, Earnings Report - Annual Results, standalone, All financials are in JPY Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
15.3%
16.3%
 8,299.16,827.96,954.15,409.83,341.63,908.33,433.1
Cost Of Rev. Ann.
14.9%
15.4%
 6,052.95,259.15,051.63,994.42,912.72,957.52,476.3
Gross Profit Ann.
16.6%
18.8%
 2,246.31,568.91,902.51,415.4429950.8956.9
Operating Exp. Ann.
7.5%
20.6%
 2,227.71,939.11,784.91,794.9957871.9842.8
Operating Profit Ann.
-
-25.1%
 18.6-370.2117.6-379.5-52878.9114.1
-
-
 -49.7-35.8-3.7-11.1-11.9-12.3-14.7
Other Exp. Ann.
-
-
 78.8426.665.9-23.8-86.8-33.9-7.4
PBT Ann.
-
7.8%
 47.720.6179.8-414.5-626.732.791.9
Tax Ann.
-
-
 -90.5-94.430.8576.3-87.51625.3
⌄
-
53.8%
 148.8115.1149-990.7-539.217.366.3
Diluted NI Avail to Com Stockholders Ann.
-
53.8%
 148.8115.1149-990.7-539.217.366.3
EPS Ann.
-
51.9%
 29.123.630.5-203.1-1343.613.8
Diluted EPS Ann.
-
51.3%
 28.522.327.2-203.1-1343.613.8
Number Of Shares End
-
-
 --4.94.94.84.7-
Total Exp. Ann.
12.7%
16.7%
 8,280.57,198.26,836.55,789.43,869.63,829.43,319.1
Net Income Continuing Discontinued Operations Ann.
-
53.8%
 148.8115.1149-990.7-539.217.366.3
Normalized Income Ann.
-
22.6%
 121.2-223.3136.7-957.3-447.643.771.8
Interest Income Ann.
-
-
 01.16.10.81.31.30.8
Interest Ann.
60.6%
29.6%
 49.736.99.81213.213.615.5
EBITDA Ann.
-
33.2%
 387.5310.1373.6-276.3-551.292.5151.7
Reconciled Cost Of Rev. Ann.
14.9%
15.4%
 6,052.95,259.15,051.63,994.42,912.72,957.52,476.3
Reconciled Depr. Ann.
32%
44.4%
 290252.6184.1126.262.346.244.3
Profit From Continuing Operations Ann.
-
51.5%
 138.2115.1149-990.7-539.217.366.3
Normalized EBITDA Ann.
-
21.9%
 351.6-130.4358.8-228.1-444.7130.6159.2
*All financials are in JPY Million and price data in USD
Total Rev. Ann.
1Y CHG
21.5%
2Y CAGR
9.2%
3Y CAGR
15.3%
5Y CAGR
16.3%
Net Profit Ann.
1Y CHG
29.3%
2Y CAGR
-0.1%
5Y CAGR
53.8%
Operating Exp. Ann.
1Y CHG
14.9%
2Y CAGR
11.7%
3Y CAGR
7.5%
5Y CAGR
20.6%

MEDIROM Healthcare Tech Inc (ADR) balance sheet as of Dec 2024: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund MEDIROM Healthcare Tech Inc (ADR) Dec-2024 Total Shareholders Fund is $933 Million which is growth of 342.6% YoY.

  • POSITIVE

    Total Assets MEDIROM Healthcare Tech Inc (ADR) Dec-2024 Total Assets is $8,091 Million which is growth of 18.1% YoY.

MEDIROM Healthcare Technologies Inc - ADR, Balance Sheet, standalone, All financials are in JPY Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
12%
11.2%
8,090.76,849.26,747.45,753.15,713.54,757.54,522
⌄
5%
10.7%
6,902.66,633.26,806.75,961.45,222.24,157.44,639.5
⌄
-
9.2%
933.3210.9-59.4-208.3491.3600.1-117.6
Total Capitalization Ann.
46.6%
17.7%
1,697.51,261.71,090.4538.31,159.6750.6225.2
Tangible Assets Ann.
-
-
-595.2-1,194.4-1,002.5-1,199.7242.9444.1-257.8
Working Capital Ann.
-
-
-1,475.4-1,801.9-1,278.8-1,814.2-565.4-884-1,416.8
Invested Capital Ann.
58.9%
20.2%
2,8101,762.11,189.6700.51,401.91,122.2639
Tangible Book Value Ann.
-
-
-595.2-1,194.4-1,002.5-1,199.7242.9444.1-257.8
Borrowings Ann.
12.3%
10.9%
3,9573,649.33,231.32,792.82,561.92,362.92,848.9
Net Debt Ann.
42.2%
183.2%
1,547.31,444.9643.5538.2-8.5544.8
Share Issued Ann.
17%
11.2%
85554.94.74.7
Number Of Shares End
-
-
--4.94.94.84.7-
*All financials are in JPY Million and price data in USD
Total Assets Ann.
1Y CHG
18.1%
2Y CAGR
9.5%
3Y CAGR
12%
5Y CAGR
11.2%
Total Current Liabilities Ann.
1Y CHG
17.4%
2Y CAGR
7.2%
3Y CAGR
9.4%
5Y CAGR
13.1%
Total ShareHolders Funds Ann.
1Y CHG
342.5%
5Y CAGR
9.2%

MEDIROM Healthcare Tech Inc (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2024 – 11 year history

  • POSITIVE

    Book Value Per Share MEDIROM Healthcare Tech Inc (ADR) Book Value Per Share is $0 which is growth of 140.3% YoY.

  • POSITIVE

    ROE MEDIROM Healthcare Tech Inc (ADR) ROE is 26% which is growth of 125.9% YoY.

MEDIROM Healthcare Technologies Inc - ADR, Ratios, standalone, All financials are in JPY Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
RoA Ann. %
-
40%
1.99%1.69%2.38%-17.28%-10.30%0.37%1.47%
ROE Ann. %
-
29.3%
26.00%151.88%--700.38%-98.81%7.19%-
ROIC %
-
-
-------
OPM Ann. %
-
-35.8%
0.22%-5.42%1.69%-7.02%-15.80%2.02%3.32%
Inventory Turnover Ratio Ann.
-48.3%
-39.1%
41.541.476.1299.7432.6496.5386.7
Asset Turnover Ann. %
6.9%
6.6%
1.111.10.90.60.80.8
Working Capital Turnover Ann.
-
-
-5.6-3.8-5.4-3-5.9-4.4-2.4
Quick Ratio Ann.
14.5%
0%
0.60.40.50.40.80.60.4
Current Ratio Ann.
20.5%
3.1%
0.70.50.70.40.80.60.4
Interest Coverage Ratio Ann.
-
-10.1%
21.619.3-33.7-46.43.46.9
LT Debt To Equity Ann.
-
0%
2.211.3--3.42.2-
*All financials are in JPY Million and price data in USD
ROE Ann. %
1Y CHG
-82.9%
5Y CAGR
29.3%
RoA Ann. %
1Y CHG
17.8%
2Y CAGR
-8.6%
5Y CAGR
40%
Current Ratio Ann.
1Y CHG
40%
3Y CAGR
20.5%
5Y CAGR
3.1%

MEDIROM Healthcare Tech Inc (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2024 – 11 year history

  • NEGATIVE

    Cash From Operating Activity MEDIROM Healthcare Tech Inc (ADR) Dec-2024 Cash From Operating Activity is $-1,332 Million which is growth of -110.8% YoY.

  • POSITIVE

    Net Cash Flow MEDIROM Healthcare Tech Inc (ADR) Dec-2024 Net Cash Flow is $223 Million which is growth of 144.7% YoY.

MEDIROM Healthcare Technologies Inc - ADR, Cash Flow, standalone, All financials are in JPY Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
-
-
-1,331.7-631.7-685.7-557.2-366.47.9141.9
-
-
361.4-328.6580.4-83.9-139.6-37.9-79.4
-
29.2%
1,193.3461.2340.1-4281,432.1332-74.5
Cash Plus Cash Eqv. End Of Year Ann.
-3.9%
-8.5%
329.4106.4605.5370.61,439.7513.6211.7
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-5.9%
223.1-499.1234.8-1,069.1926.1301.9-12
Cash Plus Cash Eqv. Begin Of Year Ann.
-58%
-12.9%
106.4605.5370.61,439.7513.6211.7223.7
Income Tax Paid Supplemental Data Ann.
-34.5%
-12%
12.852.130.845.5724.314.8
Interest Paid Supplemental Data Ann.
63.5%
32%
47.634.67.510.910.211.917
Capex Ann.
-
-
-564.8-922-166.5-113.8-104.1-19.5-50.1
Issuance Of Capital Stock Ann.
-
4.4%
868.4-1,168.6700
Issuance Of Debt Ann.
-
-
1,010400547.6775270
Repayment Of Debt Ann.
-
-
-685-99.1-207.5-251.1-386.4-241.9-344.5
Repurchase Of Capital Stock Ann.
-
-
-------
Free Cash Flow Ann.
-
-
-1,896.5-1,553.8-852.2-671-470.6-11.691.8
*All financials are in JPY Million and price data in USD
Cash from Investing Act. Ann.
2Y CAGR
-21.1%
Cash from Financing Act. Ann.
1Y CHG
158.7%
2Y CAGR
87.3%
5Y CAGR
29.2%